IRONWOOD PHARMACEUTICALS INC - NOTE 0.750% 6/1 Institutional Ownership

13F Institutional Holders and Ownership History from Q3 2020 to Q2 2024

Type / Class
Debt / NOTE 0.750% 6/1
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors

Institutional Holders of IRONWOOD PHARMACEUTICALS INC - NOTE 0.750% 6/1 across Reporting Periods

Period Principal Value Change Price (% of par) (Median) Investors
2024 Q2 $0 $0 -$207,667,422 0
2024 Q1 $208,742,000 $207,667,098 +$2,952,181 99.26% 17
2023 Q4 $202,375,000 $213,555,437 -$60,883 104.92% 18
2023 Q3 $205,992,000 $204,392,316 +$4,423,165 98.78% 23
2023 Q2 $201,479,698 $202,585,488 +$1,623,846 100.38% 23
2023 Q1 $199,988,894 $201,130,923 +$25,329,095 100.29% 20
2022 Q4 $174,191,432 $187,863,857 -$6,554,945 107.52% 24
2022 Q3 $187,654,388 $188,662,372 -$11,841,882 100.29% 24
2022 Q2 $199,191,750 $209,871,718 -$19,519,214 105.34% 20
2022 Q1 $215,005,500 $243,411,548 +$18,571,230 114.5% 20
2021 Q4 $198,942,000 $221,349,442 -$587,968 111.2% 19
2021 Q3 $199,014,000 $234,842,035 -$184,148 118.26% 19
2021 Q2 $199,137,000 $234,262,243 -$9,492 117.99% 19
2021 Q1 $199,302,000 $220,643,152 -$39,613 110.82% 18
2020 Q4 $199,128,000 $223,201,181 -$586,304 112.05% 19
2020 Q3 $199,857,000 $197,756,047 +$197,756,047 99.0% 18